LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
3.2.4 Research funding
The department intensified the procurement of thirdparty
funding in the reporting period. Since research
in psychotherapy/psychosomatic medicine is very staff
intensive, the procurement of staff positions lies at the heart
of procuring third party funding. For the period 2001–2008
there were three funded research focuses:
Within the context of psychotherapy research, the DFG
supported the Düsseldorf short-time psychotherapy
study, which aims to investigate the processes and
outcomes of short-term psychotherapies in a range of
disorders. In addition, the resources of the Heigl-Evers
Foundation allowed the analysis of the differential effects
of this intervention in patients with early traumatisation.
At the same time, the DFG funded a study of inpatients
with personality disorders. In collaboration with the
Association of Dependence Help (Gesamtverband der
Suchtkrankenhilfe), a concept was evaluated for quality
assurance in inpatient dependence treatment.
The second focus of the funding is in the area of
basic psychosomatic care, which is used to integrate
psychosomatic aspects into general medical care. In
this way, the FMER, within the context of a public health
research focus, supports a healthcare-epidemiology study,
which estimates the prevalence of mental disorders in
general practice and assesses the determinants of general
practitioners’ diagnostic evaluation of mental disorders.
Thanks to the financial support of the North Rhine Statutory
Health Insurance Physicians’ Association (KV Nordrhein) and
the Rhineland Health Insurance Funds (AOK Rhineland), we
assess within the context of a model project the possibility of
modifying the communicative behaviour of doctors dealing
with oncology patients.
The third publicly funded research area deals with
somatoform disorders. In a DFG-funded project, the
influence of severe traumatisation on healthcare utilisation
by patients with functional disorders is being studied. The
Faculty of Medicine is supporting a study that analyses the
influence of post-traumatic disorders on the development
of functional syndromes in migrants from the former
Yugoslavia.
All in all, within the reporting period, third-party funding
amounting to ca. 821,000 Euro was obtained, making the
mean annual third-party funding income ca. 91,000 Euro
(Range: 17,000 to 177,000 Euro/p.a.).
168
Third-party funded projects:
The return of torture?
Applicants: C. Altenhain, R. Görling, J. Kruse. Own area
of research Mental and neurobiological consequences
of extreme violence; funding period: 2008–2011, funding
organisation: Volkswagen Foundation
The influence of inpatient/partial-inpatient
psychotherapeutic treatment on subclinical inflammation
in patients with depression
Applicants: B. Rose, J. Kruse; funding period: 2008–2009;
funding organisation: Heigl Foundation
Evaluation of the “JaVita” patient chaperonage for patients
with oncological illnesses
Applicants: J. Kruse, J. Hardt; funding period: 2008–2009;
funding organisation: AOK Rhineland Hamburg
Traumatic life events and psychosomatic interactions in
people with diabetes mellitus
Applicants: J. Kruse, K. H. Ladwig, A. Icks, C. Herder,
W. Rathmann, S. Martin, N. Schmitz; funding period:
2007–2008; funding organisation: Heigl Foundation
Life after Torture - beyond PTSD
Applicants: Psychosocial centre for refugees, Düsseldorf;
Cooperation partner: J. Kruse, L. Joksimovic; funding
period: 2006–2008; funding organisation: European
Commission, European Initiative for Democracy and Human
Rights within the Rehabilitation of Victims of Torture funding
focus
Evaluation of the prevention measure “My body belongs to
me” for the prevention of sexual abuse
Applicants: J. Kruse, U. Bowi, G. Ott, W. Tress; funding
period: 2006–2007; funding organisation: NRW state
Cognitive Behavioural Therapy vs. sertraline in patients
with depression and poorly controlled diabetes mellitus: A
randomised controlled trial (DAD study)
Applicants: F. Petrak, J. Kruse, B. Kulzer, R. Meinert,
M. Müller, N. Hermanns, S. Herpertz, Schmidt; funding
period: 2005–2008; funding organisation: DFG/FMER within
a clinical studies funding programme